Have a feature idea you'd love to see implemented?
Let us know!
COEP Coeptis Therapeutics Holdings Inc
Price (delayed)
$0.1899
Market cap
$7.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.28
Enterprise value
$8.45M
Highlights
The equity has soared by 155% year-on-year
The EPS has soared by 63% YoY and by 40% QoQ
The quick ratio has declined by 48% year-on-year and by 23% since the previous quarter
Coeptis Therapeutics Holdings's debt has increased by 31% YoY
Key stats
What are the main financial stats of COEP
Market
Valuations
Earnings
Shares outstanding
41.12M
Market cap
$7.81M
Enterprise value
$8.45M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$11.29M
EBITDA
-$10.26M
Free cash flow
-$6.91M
Per share
Balance sheet
Liquidity
EPS
-$0.28
Free cash flow per share
-$0.17
Book value per share
$0.12
Revenue per share
$0
TBVPS
$0.22
Total assets
$8.96M
Total liabilities
$3.97M
Debt
$1.77M
Equity
$4.82M
Working capital
-$2.08M
Debt to equity
0.37
Current ratio
0.4
Quick ratio
0.33
Net debt/EBITDA
-0.06
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-215%
Return on equity
-1,146.2%
Return on invested capital
-486.4%
Return on capital employed
-204.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
COEP stock price
How has the Coeptis Therapeutics Holdings stock price performed over time
Intraday
-1.96%
1 week
-7.59%
1 month
-14.46%
1 year
-83.77%
YTD
-75.77%
QTD
5.56%
Financial performance
How have Coeptis Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.26M
Net income
-$11.62M
Gross margin
N/A
Net margin
N/A
Coeptis Therapeutics Holdings's operating income has increased by 47% YoY and by 34% from the previous quarter
COEP's net income is up by 43% YoY and by 28% from the previous quarter
Growth
What is Coeptis Therapeutics Holdings's growth rate over time
Valuation
What is Coeptis Therapeutics Holdings stock price valuation
P/E
N/A
P/B
1.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 63% YoY and by 40% QoQ
The equity has soared by 155% year-on-year
Efficiency
How efficient is Coeptis Therapeutics Holdings business performance
Coeptis Therapeutics Holdings's return on invested capital has surged by 98% YoY and by 79% QoQ
The company's return on equity has surged by 80% QoQ but it fell by 28% YoY
COEP's return on assets is up by 42% since the previous quarter and by 32% year-on-year
Dividends
What is COEP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for COEP.
Financial health
How did Coeptis Therapeutics Holdings financials performed over time
The total assets is 125% greater than the total liabilities
The total assets has surged by 113% since the previous quarter and by 92% year-on-year
The quick ratio has declined by 48% year-on-year and by 23% since the previous quarter
Coeptis Therapeutics Holdings's debt is 63% less than its equity
The equity has soared by 155% year-on-year
COEP's debt to equity has surged by 109% since the previous quarter but it is down by 48% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.